Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | KLKB1 | P03952 | 1/20 | 0.40 |
| ▸ | CA1 | P00915 | 4/20 | 0.38 |
| ▸ | CA2 | P00918 | 4/20 | 0.38 |
| ▸ | CA7 | P43166 | 3/20 | 0.38 |
| ▸ | CA9 | Q16790 | 3/20 | 0.38 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.38 |
| ▸ | SCN9A | Q15858 | 2/20 | 0.35 |
| ▸ | NR3C1 | P04150 | 2/20 | 0.34 |
| ▸ | NPC1 | O15118 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | NAMPT | P43490 | 1/20 | 0.34 |
| ▸ | BCHE | P06276 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1659194 | 0.90 | KLKB1 (0.40) | POLBKLKB1CA1CA2CA7 | |
| SCHEMBL1658941 | 0.90 | KLKB1 (0.40) | POLBKLKB1SCN9ANPC1RAB9A | |
| SCHEMBL1659509 | 0.89 | KLKB1 (0.39) | POLBKLKB1 | |
| SCHEMBL1661398 | 0.89 | KLKB1 (0.39) | POLBKLKB1CA1CA2CA7 | |
| SCHEMBL1660515 | 0.88 | SCN9A (0.40) | POLBKLKB1SCN9ARAB9A | |
| SCHEMBL1660390 | 0.87 | KLKB1 (0.38) | POLBKLKB1CA1CA2CA7 | |
| SCHEMBL1659442 | 0.86 | KLKB1 (0.37) | POLBKLKB1CA1CA2CA7 | |
| SCHEMBL1661096 | 0.86 | KLKB1 (0.37) | POLBKLKB1CA1CA2CA7 | |
| SCHEMBL12697436 | 0.84 | KCNQ3 (0.38) | KLKB1 | |
| SCHEMBL1985034 | 0.84 | KCNQ3 (0.38) | KLKB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2307394-A2 | NOVEL COMPOUNDS, ISOMER THEREOF, OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS VANILLOID RECEPTOR ANTAGONIST AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME | Amorepacific Corporation (KR) | 2011-04-13 | — | — | EP | disclosed |